OR WAIT null SECS
The evolution of therapeutic modalities drives the adoption of single-use technologies.
Despite its understandable hesitancy, the pharma industry is facing a need for more widespread adoption of cloud-based solutions.
Given the criticality of fill/finish processes, it is clear that automation is the next technological step.
July 27, 2022
WuXi STA is opening a new large-scale oligonucleotide and peptide manufacturing facility.
July 19, 2022
Guest contributor Frederic Kahn discusses the state of the Indian pharmaceutical manufacturing industry.
TFF Pharmaceuticals is expanding its R&D operations with a new facility in Austin, Texas.
In this episode, Grant Playter, assistant editor, sits down with Rosalind Beasley, vice president, Digital Innovation, Dot Compliance, to discuss the current state of the compliance and validation industry.
Cytiva has acquired a new chromatography resins manufacturing site in the United States as part of its $1.5 billion capacity expansion investment.
July 15, 2022
Exhibitors display innovations for parenteral and solid dose products.
July 13, 2022
Pfizer and Touchlight have signed a patent license agreement for Pfizer to use Touchlight’s doggybone DNA (dbDNA) in the manufacture of mRNA vaccines, therapeutics, and gene therapies.
July 12, 2022
Wacker is investing more than €100 million (US$100.5 million) to expand its Halle, Germany, site with an mRNA competence center.
In this episode, experts share their insights into important drug packaging advances of the past, present, and future.
July 08, 2022
VeriSIM Life and Mayo Clinic are collaborating to develop new promising drug candidates.